2025 Updates on Thyroid Cancer Management

UNC Lineberger Comprehensive Cancer Center

C. Blake Sullivan

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

Managing Patients With RAIR-DTC in 2L Setting

Fabian Pitoia

2024 Advances in Thyroid Cancer Treatment

GRACE

J. Weiss, S. Patel, S. Sheth

Understanding Differentiated Thyroid Cancer & Multidisciplinary Trea…

Sarimar Agosto Salgado

Challenging Thyroid Cancer Cases from USC to the Panel

Keck School of Medicine of USC

C. T. Nguyen, T. Angell

Hashimoto's and Thyroid Cancer: Q&A Session

Keck School of Medicine of USC

T. Angell, M. Haymart

The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

Cabozantinib for VEGFR TKI-Resistant Differentiated Thyroid Cancer: …

Bhumsuk Keam

Recent Advances in Treatment of Thyroid Cancer With Precision Medici…

Jefferson Health

M. Brose

The Role of Medical Oncologists in the Treatment of RAI-Refractory D…

Francis Worden

Thyroid Nodule Fine Needle Aspiration

Jefferson Health

J. Sheehan

Comprehensive Workup of Thyroid Nodules

Jefferson Health

R. Haddad

Updates in 2022 WHO Classification of Thyroid Neoplasms

Jefferson Health

M. Tuluc

Disparities in Thyroid Cancer Care - Where Can We Improve?

Keck School of Medicine of USC

M. Haymart

Role of Radiation Therapy for Thyroid Eye Disease

Boston University Chobanian & Avedisian School of Medicine

M. T. Truong

Is It Possible? Thyroglobulin as a Tumor Marker after Lobectomy for …

Keck School of Medicine of USC

T. Angell

Thyroid Radiofrequency Ablation

Jefferson Health

E. Cottrill

Parathyroid Disease and Tumors

Yale Cancer Center

C. Gibson

Dabrafenib and Trametinib in BRAF Mutant Thyroid Cancer: Results Fro…

Bhumsuk Keam